A small amount of fat does not affect piperaquine exposure in patients with malaria.

A small amount of fat does not affect piperaquine exposure in patients with malaria.

Εμφάνιση άλλων εκδόσεων (1)

Dihydroartemisinin-piperaquine is a new, highly effective, and well-tolerated combination treatment for uncomplicated falciparum malaria. The lipophilic characteristic of piperaquine suggests that administration together with fat will increase the oral bioavailability of the drug, and this has been...

Πλήρης περιγραφή

Λεπτομέρειες βιβλιογραφικής εγγραφής
Κύριοι συγγραφείς:	Annerberg, A, Lwin, K, Lindegardh, N, Khrutsawadchai, S, Ashley, E, Day, N, Singhasivanon, P, Tarning, J, White, N, Nosten, F
Μορφή:	Journal article
Γλώσσα:	English
Έκδοση:	2011

Παρόμοια τεκμήρια

A small amount of fat does not affect piperaquine exposure in patients with malaria.
ανά: Annerberg, A, κ.ά.
Έκδοση: (2011)

Population pharmacokinetic assessment of the effect of food on piperaquine bioavailability in patients with uncomplicated malaria.
ανά: Tarning, J, κ.ά.
Έκδοση: (2014)

Comparison of plasma, venous and capillary blood levels of piperaquine in patients with uncomplicated falciparum malaria.
ανά: Ashley, E, κ.ά.
Έκδοση: (2010)

Comparison of plasma, venous and capillary blood levels of piperaquine in patients with uncomplicated falciparum malaria
ανά: Ashley, E, κ.ά.
Έκδοση: (2010)

Pitfalls in estimating piperaquine elimination.
ανά: Tarning, J, κ.ά.
Έκδοση: (2005)

Population pharmacokinetics of piperaquine after two different treatment regimens of dihydroartemisinin piperaquine in patients with acute uncomplicated falciparum malaria in Thailand
ανά: Tarning, J, κ.ά.
Έκδοση: (2007)

Population pharmacokinetics of piperaquine after two different treatment regimens with dihydroartemisinin-piperaquine in patients with Plasmodium falciparum malaria in Thailand.
ανά: Tarning, J, κ.ά.
Έκδοση: (2008)

Randomized, double-blind, placebo-controlled trial of monthly versus bimonthly dihydroartemisinin-piperaquine chemoprevention in adults at high risk of malaria
ανά: Lwin, K, κ.ά.
Έκδοση: (2012)

Randomized, double-blind, placebo-controlled trial of monthly versus bimonthly dihydroartemisinin-piperaquine chemoprevention in adults at high risk of malaria.
ανά: Lwin, K, κ.ά.
Έκδοση: (2012)

Population pharmacokinetics of dihydroartemisinin and piperaquine in pregnant and nonpregnant women with uncomplicated malaria.
ανά: Tarning, J, κ.ά.
Έκδοση: (2012)

Population Pharmacokinetics and Antimalarial Pharmacodynamics of Piperaquine in Patients With Plasmodium vivax Malaria in Thailand.
ανά: Tarning, J, κ.ά.
Έκδοση: (2014)

Population pharmacokinetics and antimalarial pharmacodynamics of piperaquine in patients with plasmodium vivax malaria in Thailand
ανά: Tarning, J, κ.ά.
Έκδοση: (2014)

Dihydroartemisinin-piperaquine versus chloroquine in the treatment of Plasmodium vivax malaria in Thailand: a randomized controlled trial.
ανά: Phyo, A, κ.ά.
Έκδοση: (2011)

Population Pharmacokinetics of Dihydroartemisinin and Piperaquine in Pregnant and Nonpregnant Women with Uncomplicated Malaria
ανά: Tarning, J, κ.ά.
Έκδοση: (2012)

Pharmacokinetics of dihydroartemisinin and piperaquine in pregnant and nonpregnant women with uncomplicated falciparum malaria.
ανά: Rijken, M, κ.ά.
Έκδοση: (2011)

Characterization of an in vivo concentration-effect relationship for piperaquine in malaria chemoprevention.
ανά: Bergstrand, M, κ.ά.
Έκδοση: (2014)

Development and validation of a liquid chromatographic-tandem mass spectrometric method for determination of piperaquine in plasma stable isotope labeled internal standard does not always compensate for matrix effects.
ανά: Lindegardh, N, κ.ά.
Έκδοση: (2008)

Development and validation of an automated solid phase extraction and liquid chromatographic method for the determination of piperaquine in urine.
ανά: Tarning, J, κ.ά.
Έκδοση: (2006)

Population pharmacokinetics and pharmacodynamics of piperaquine in children with uncomplicated falciparum malaria.
ανά: Tarning, J, κ.ά.
Έκδοση: (2012)

Population pharmacokinetics and pharmacodynamics of piperaquine in children with uncomplicated falciparum malaria
ανά: Tarning, J, κ.ά.
Έκδοση: (2012)

Pharmacokinetics of piperaquine in pregnant women in Sudan with uncomplicated Plasmodium falciparum malaria.
ανά: Adam, I, κ.ά.
Έκδοση: (2012)

Efficacy and day 7 plasma piperaquine concentrations in African children treated for uncomplicated malaria with dihydroartemisinin-piperaquine
ανά: Zongo, I, κ.ά.
Έκδοση: (2014)

Pharmacokinetics of piperaquine in pregnant women in Sudan with uncomplicated Plasmodium falciparum malaria
ανά: Adam, I, κ.ά.
Έκδοση: (2012)

A population pharmacokinetic model of piperaquine in pregnant and non-pregnant women with uncomplicated Plasmodium falciparum malaria in Sudan.
ανά: Hoglund, R, κ.ά.
Έκδοση: (2012)

Quantification of the antimalarial piperaquine in plasma.
ανά: Tarning, J, κ.ά.
Έκδοση: (2008)

A RANDOMISED, DOUBLE-BLIND PLACEBO CONTROLLED TRIAL OF TWO DIFFERENT DOSING REGIMENS OF DIHYDROARTEMISININ-PIPERAQUINE FOR INTERMITTENT PREVENTIVE TREATMENT OF ADULTS AT HIGH RISK OF MALARIA IN THAILAND
ανά: Lwin, K, κ.ά.
Έκδοση: (2010)

Pharmacokinetic evaluation and metabolite characterization of the antimalarial piperaquine in the rat
ανά: Tarning, J, κ.ά.
Έκδοση: (2007)

Pharmacokinetics and metabolism of the antimalarial piperaquine after intravenous and oral single doses to the rat.
ανά: Tarning, J, κ.ά.
Έκδοση: (2008)

Electrocardiographic safety evaluation of dihydroartemisinin piperaquine in the treatment of uncomplicated falciparum malaria.
ανά: Mytton, O, κ.ά.
Έκδοση: (2007)

Characterization of human urinary metabolites of the antimalarial piperaquine.
ανά: Tarning, J, κ.ά.
Έκδοση: (2006)

Population pharmacokinetics of lumefantrine in pregnant women treated with artemether-lumefantrine for uncomplicated Plasmodium falciparum malaria.
ανά: Tarning, J, κ.ά.
Έκδοση: (2009)

Efficacy and safety of dihydroartemisinin-piperaquine.
ανά: Myint, H, κ.ά.
Έκδοση: (2007)

Efficacy and day 7 plasma piperaquine concentrations in African children treated for uncomplicated malaria with dihydroartemisinin-piperaquine.
ανά: Issaka Zongo, κ.ά.
Έκδοση: (2014-01-01)

A population pharmacokinetic model of piperaquine in pregnant and non-pregnant women with uncomplicated <it>Plasmodium falciparum</it> malaria in Sudan
ανά: Hoglund Richard M, κ.ά.
Έκδοση: (2012-11-01)

How much fat is necessary to optimize lumefantrine oral bioavailability?
ανά: Ashley, E, κ.ά.
Έκδοση: (2007)

Efficacy and effectiveness of dihydroartemisinin-piperaquine versus artesunate-mefloquine in falciparum malaria: an open-label randomised comparison.
ανά: Smithuis, F, κ.ά.
Έκδοση: (2006)

Population pharmacokinetic properties of Piperaquine in Falciparum Malaria: an individual participant data-level meta-analysis
ανά: Hoglund, R, κ.ά.
Έκδοση: (2017)

Dihydroartemisinin - piperaquine rescue treatment of multidrug-resistant Plasmodium falciparum malaria in pregnancy: a preliminary report
ανά: Rijken, M, κ.ά.
Έκδοση: (2007)

Optimal dosing of dihydroartemisinin-piperaquine for seasonal malaria chemoprevention in young children
ανά: Chotsiri, P, κ.ά.
Έκδοση: (2019)

Dihydroartemisinin-piperaquine versus chloroquine to treat vivax malaria in Afghanistan: an open randomized, non-inferiority, trial.
ανά: Awab, G, κ.ά.
Έκδοση: (2010)